Lineage Cell Therapeutics Inc (LCTX) — Tangible Net Worth Ratio
Lineage Cell Therapeutics Inc (LCTX) has a Tangible Net Worth Ratio of -52.4% as of September 2025. This metric is calculated by deducting intangible assets ($31.70 Million) from net assets ($20.80 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore net asset momentum of Lineage Cell Therapeutics Inc to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Lineage Cell Therapeutics Inc Tangible Net Worth Ratio (1991–2024)
This chart shows how Lineage Cell Therapeutics Inc's Tangible Net Worth Ratio has changed across 27 annual periods from 1991 to 2024. As of September 2025, the ratio stands at -52.4%, reflecting net assets of $20.80 Million with intangible assets of $31.70 Million USD. For live market cap and overall valuation, see LCTX company net worth.
Annual Tangible Net Worth Ratio for Lineage Cell Therapeutics Inc (1991–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Lineage Cell Therapeutics Inc from 1991 to 2024, covering 27 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore Lineage Cell Therapeutics Inc (LCTX) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 39.6% | $77.01 Million | $46.54 Million | $113.22 Million | ▲ +14.6 pp |
| 2023 | 24.9% | $62.02 Million | $46.56 Million | $101.02 Million | ▼ -10.2 pp |
| 2022 | 35.1% | $71.94 Million | $46.69 Million | $123.66 Million | ▼ -13.4 pp |
| 2021 | 48.5% | $90.90 Million | $46.82 Million | $174.54 Million | ▼ -2.1 pp |
| 2020 | 50.6% | $95.13 Million | $47.03 Million | $107.95 Million | ▼ -6.1 pp |
| 2019 | 56.6% | $111.25 Million | $48.25 Million | $125.48 Million | ▼ -40.0 pp |
| 2018 | 96.6% | $92.25 Million | $3.12 Million | $101.66 Million | ▲ +0.8 pp |
| 2017 | 95.8% | $164.26 Million | $6.90 Million | $173.24 Million | ▲ +3.6 pp |
| 2016 | 92.2% | $130.51 Million | $10.21 Million | $142.57 Million | ▲ +36.1 pp |
| 2015 | 56.1% | $76.45 Million | $33.59 Million | $94.66 Million | ▲ +18.0 pp |
| 2014 | 38.1% | $62.72 Million | $38.85 Million | $74.90 Million | ▲ +47.4 pp |
| 2013 | -9.3% | $42.26 Million | $46.21 Million | $57.73 Million | ▼ -25.0 pp |
| 2012 | 15.7% | $24.29 Million | $20.49 Million | $29.75 Million | ▼ -39.4 pp |
| 2011 | 55.1% | $41.46 Million | $18.62 Million | $45.83 Million | ▼ -13.8 pp |
| 2010 | 68.9% | $49.43 Million | $15.39 Million | $53.27 Million | ▼ -31.1 pp |
| 2009 | 100.0% | $11.05 Million | $0.00 | $13.43 Million | ▲ +0.0 pp |
| 2004 | 100.0% | $344.77K | $0.00 | $1.52 Million | ▲ +0.0 pp |
| 2000 | 100.0% | $1.32 Million | $0.00 | $1.68 Million | ▲ +0.0 pp |
| 1999 | 100.0% | $5.08 Million | $0.00 | $5.68 Million | ▲ +0.0 pp |
| 1998 | 100.0% | $2.40 Million | $0.00 | $2.80 Million | ▲ +0.0 pp |
| 1997 | 100.0% | $6.50 Million | $0.00 | $8.30 Million | ▲ +0.0 pp |
| 1996 | 100.0% | $2.80 Million | $0.00 | $3.00 Million | ▲ +0.0 pp |
| 1995 | 100.0% | $2.80 Million | $0.00 | $3.00 Million | ▲ +0.0 pp |
| 1994 | 100.0% | $3.20 Million | $0.00 | $3.60 Million | ▲ +0.0 pp |
| 1993 | 100.0% | $5.80 Million | $0.00 | $5.90 Million | ▲ +0.0 pp |
| 1992 | 100.0% | $3.40 Million | $0.00 | $3.50 Million | ▲ +0.0 pp |
| 1991 | 100.0% | $4.60 Million | $0.00 | $4.80 Million | — |